Literature DB >> 24500271

Significant reduction of AECOPD hospitalisations after implementation of a public smoking ban in Graubünden, Switzerland.

Frank Dusemund1, Florent Baty1, Martin H Brutsche1.   

Abstract

PURPOSE: Only a few studies have examined the effect of public smoking bans on respiratory conditions. These showed reduced admission rates for different respiratory diseases.
OBJECTIVE: The objective of the present study was to evaluate the effect of the public smoking ban implemented in Graubünden, Switzerland, on the incidence of acute hospital admissions for acute exacerbated chronic obstructive pulmonary disease (AECOPD).
METHODS: We searched a database, including all nationwide hospitalisations in Switzerland, for AECOPD and analysed incidence rates before and after introduction of the smoking ban using Poisson regression and incidence rate ratios (IRRs).
RESULTS: After introduction of the smoking ban, we observed a significant 22.4% decrease in the incidence of AECOPD hospitalisations in Graubünden (IRR=0.78 (0.68 to 0.88), p<0.001). In the same period, the incidence of AECOPD hospitalisations only slightly decreased by 7.0% in the rest of Switzerland (IRR=0.93 (0.91 to 0.95), p<0.001). The observed reduction in AECOPD hospitalisation incidence was significantly greater in GR than in the rest of CH (p=0.008).
CONCLUSIONS: Our study supports the limited body of evidence demonstrating that a reduction of secondhand smoke by legislated bans on smoking is associated with reduced rates of admission to hospital for respiratory conditions, hereby shown for AECOPD, in addition to the meanwhile well-documented impact on cardiovascular disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Environment; Global health; Harm Reduction; Public policy; Secondhand smoke

Mesh:

Year:  2014        PMID: 24500271     DOI: 10.1136/tobaccocontrol-2013-051290

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  8 in total

1.  The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells.

Authors:  Di Jiang; Reena Berman; Qun Wu; Connor Stevenson; Hong Wei Chu
Journal:  J Clin Cell Immunol       Date:  2016-12-05

Review 2.  Smokefree legislation effects on respiratory and sensory disorders: A systematic review and meta-analysis.

Authors:  Yolanda Rando-Matos; Mariona Pons-Vigués; María José López; Rodrigo Córdoba; José Luis Ballve-Moreno; Elisa Puigdomènech-Puig; Vega Estíbaliz Benito-López; Olga Lucía Arias-Agudelo; Mercè López-Grau; Anna Guardia-Riera; José Manuel Trujillo; Carlos Martin-Cantera
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

3.  Using Demographic Factors and Comorbidities to Develop a Predictive Model for ICU Mortality in Patients with Acute Exacerbation COPD.

Authors:  Sukrit S Jain; Indra Neil Sarkar; Paul C Stey; Rajsavi S Anand; Dustin R Biron; Elizabeth S Chen
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

4.  Effect of high-level fine particulate matter and its interaction with meteorological factors on AECOPD in Shijiazhuang, China.

Authors:  Beibei Song; Huiran Zhang; Libin Jiao; Zeng Jing; Honglin Li; Siyu Wu
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 5.  Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption.

Authors:  Kate Frazer; Joanne E Callinan; Jack McHugh; Susan van Baarsel; Anna Clarke; Kirsten Doherty; Cecily Kelleher
Journal:  Cochrane Database Syst Rev       Date:  2016-02-04

6.  Changes in hospitalizations for chronic respiratory diseases after two successive smoking bans in Spain.

Authors:  Iñaki Galán; Lorena Simón; Elena Boldo; Cristina Ortiz; Rafael Fernández-Cuenca; Cristina Linares; María José Medrano; Roberto Pastor-Barriuso
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

7.  Acute exacerbations of chronic obstructive pulmonary disease in a cohort of Chinese never smokers goes along with decreased risks of recurrent acute exacerbation, emphysema and comorbidity of lung cancer as well as decreased levels of circulating eosinophils and basophils.

Authors:  Guangdong Wang; Aiping Ma; Liang Zhang; Jiaxi Guo; Qun Liu; Frank Petersen; Zhanxiang Wang; Xinhua Yu
Journal:  Front Med (Lausanne)       Date:  2022-08-10

8.  Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007-2012.

Authors:  Zhen Fu; Hongwei Jiang; Zhongyu Xu; Hongyu Li; Nanjin Wu; Ping Yin
Journal:  Ann Transl Med       Date:  2020-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.